Trimurthi opened higher at ₹70.24, compared with its previous close of ₹69.12. During today's session, the stock has traded between ₹69.02 and ₹71.99, with an average traded price of ₹71.21. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Trimurthi is now worth
₹ 91,156.00
Giving a profit of
₹ 81,156.00 (811.56%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+1.88 (+2.72%)
Day High
₹71.99
Day Low
₹69.02
Day Open
₹70.24
Prev Close
₹69.12
Volume
1,644
Value Traded
₹0.01 Cr
1W Return
4.41%
1M Return
10.13%
3M Return
-2.73%
6M Return
31.17%
1Y Return
26.72%
Market Cap (₹ Cr.)
202
PE Ratio
42.20
PB Ratio
3.01
Dividend Yield
-
ROE
-26.40%
ROCE
-26.06%
Book Value (₹)
22.95
Face Value (₹)
10.00
EPS (TTM)
-0.19
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
4.41%
6 Weeks
-
1 Month
10.13%
3 Months
-2.73%
9 Months
15.84%
Novelix Pharma Q2FY27 Results: Net profit up 193% YoY to ₹156.32 lakh
Net profit rose 193% YoY to ₹156.32 lakh in Q2FY27. Revenue from operations increased 23% YoY to ₹4,473.12 lakh. Basic EPS improved to ₹0.57 from ₹0.37 in Q2FY26. Trade receivables doubled to ₹10,574.03 lakh since March 2026. New corporate office approved in Hyderabad effective Nov 16, 2026.
YesterdayNovelix Pharmaceuticals passes all AGM resolutions with 99.97% support
All three AGM resolutions passed with 99.97% votes in favor. Promoter group voted 95.96% of their holding; public non-institutions voted 31.66%. Exactly 6,010 votes cast against each resolution by two shareholders. Meeting held via video conferencing with 73 attendees.
1mo agoNovelix Pharmaceuticals schedules 32nd AGM for September 30, 2026
Novelix Pharmaceuticals schedules its 32nd AGM for September 30, 2026. The meeting will be held via Video Conferencing/OAVM. Book closure runs from September 24 to September 30, 2026. Remote e-voting is open from September 27 to September 29, 2026.
2mo agoNovelix appoints Gnana Prakash Gattu as whole time director
Novelix appoints Gnana Prakash Gattu as Whole Time Director for five years. Effective date is August 29, 2026, subject to AGM approval. Gattu has 25+ years experience in management and IT. Appointment filed with BSE on August 31, 2026.
2mo agoNovelix signs lease with promoter for Telangana algae facility
Novelix Pharmaceuticals Ltd signed a five-year lease with promoter Mr. Gnana Prakash Gattu for 37 guntas of land in Telangana to set up microalgae facilities. The deal, effective August 19, 2026, carries a monthly rent of ₹5,000 plus taxes with a 5% escalation every three years, disclosed under SEBI Regulation 30.
2mo agoNovelix Pharmaceuticals Q1 Results: Net profit turns positive, revenue up 14%
Novelix Pharmaceuticals returned to profit in Q1FY26 with a net income of ₹343.13 lakh, reversing a Q4FY26 loss of ₹721.08 lakh. Revenue grew 13.9% YoY to ₹386.03 lakh. The results reflect higher depreciation due to revised asset life estimates for buildings slated for redevelopment.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹365.60 | +0.34% | ₹3,52,816.82 | 713.70 | +18.39% | |
| ₹3,459.30 | +0.15% | ₹2,25,631.45 | 72.20 | -14.75% | |
| ₹3,185.10 | +0.16% | ₹1,69,846.09 | 89.20 | +9.18% | |
| ₹726.45 | -0.14% | ₹1,26,351.90 | 158.80 | +72.47% | |
| ₹255.75 | +0.65% | ₹1,18,315.59 | -127.70 | +50.36% | |
| ₹364.95 | +1.29% | ₹1,04,532.44 | 314.90 | +42.11% | |
| ₹1,185.60 | -0.37% | ₹76,876.75 | 34.80 | -13.86% | |
| ₹190.86 | -0.70% | ₹52,683.34 | -14.80 | -51.77% | |
| ₹96.69 | +0.72% | ₹45,297.41 | 50.00 | -30.21% | |
| ₹170.39 | +1.48% | ₹26,277.22 | -56.70 | +19.39% | |
| ₹2,689.50 | +1.71% | ₹13,074.97 | 50.40 | -15.35% | |
| ₹487.75 | -1.89% | ₹11,851.26 | 31.30 | -22.53% |
An investment of ₹10,000 made 5 years ago in Trimurthi is now worth
₹ 91,156.00
Giving a profit of
₹ 81,156.00 (811.56%)
Note: Past profits do not guarantee future returns.
